TotalMarketCap

Avalyn Pharma

AVLNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.183 B

$26.69 -2.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Avalyn Pharma (AVLN) has a market capitalization of $1.18B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

44,333,095

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #137Silence TherapeuticsSLN$1.23B
  2. #138MannkindMNKD$1.21B
  3. #139Avalyn PharmaAVLN$1.18B
  4. #140Amphastar PharmaceuticalsAMPH$1.18B
  5. #141VerastemVSTM$1.15B

What if Avalyn Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$636,925.39

Per share 23,864× higher

Bitcoin $1.53T

$34,462.92

Per share 1,291× higher

Apple $5.02T

$113,138.56

Per share 4,239× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Avalyn Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.